Hospira Logo (Labetalol 01)
Labetalol Hydrochloride Injection, Solution
Product Images NDC 0409-0125
7 FDA label images from Hospira, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 0409-0125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Structural Formula Labetalol HCl (Labetalol 02)
Chemical structure of Labetalol Hydrochloride, showing the molecular arrangement with phenyl rings, hydroxyl groups, and an amide group as part of its chemical formula.*
Hospira Logo (Labetalol 02a)
Principal Display Panel (100 mg/20 mL Vial Label)
Label for Labetalol Hydrochloride Injection, USP, 5 mg/mL (100 mg/20 mL) in a 20 mL multiple-dose vial. The label includes instructions for intravenous injection only, storage protection from freezing and light, and states the product is distributed by Hospira, Inc., Lake Forest, IL. The label also displays the NDC 0409-2267-20 and spaces for lot, expiration, and usage information.*
Principal Display Panel (100 mg/20 mL Vial Carton)
Packaging label for Labetalol Hydrochloride Injection, USP 100 mg/20 mL (5 mg/mL) in a 20 mL multiple-dose vial. The label includes dosage form, strength, distributor information (Hospira, Inc.), storage instructions, and a barcode. The label is primarily pink with black and white text.*
Labetalol 05
Labetalol Hydrochloride Injection USP 200 mg/40 mL (5 mg/mL) multiple-dose vial label by Hospira, Inc. The label shows the product is for intravenous injection only and includes storage instructions and handling precautions. The vial size is 40 mL with clear identification marks, including NDC code 0409-2267-54 and space for lot and expiration date.*
Labetalol 06
Packaging label for Labetalol Hydrochloride Injection, USP 5 mg/mL, 200 mg/40 mL multiple-dose vial by Hospira, Inc. The label indicates the product is for intravenous injection only, with instructions to protect from freezing and light and retain in carton until use. The label lists inactive ingredients and storage conditions at 20 to 25°C. The product is distributed by Hospira, Inc., Lake Forest, IL, and made in Italy.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
